Video

The Challenges of Residency Programs

Jacob Gettig, PharmD, assistant dean of the Midwestern University Chicago College of Pharmacy, describes challenges that residents may encounter during their residency programs.

Jacob Gettig, PharmD, assistant dean of the Midwestern University Chicago College of Pharmacy, describes challenges that residents may encounter during their residency programs.

Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Worried Pharmacist Suffering from Headaches and Stress. Unhappy stressed medical worker feeling overwhelmed - Image credit: nicoletaionescu | stock.adobe.com
May 16th 2025

Advocate for Change to Address Pharmacy Burnout

Kathleen Kenny, PharmD, RPh
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
An elderly Indian man with heart problems
May 16th 2025

Several Comorbidities Found to Reduce Likelihood of Pneumococcal Vaccination, While Use of Implantable Devices Heightens Odds

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Human brain digital illustration. Electrical activity, flashes and lightning on a blue background - Image credit: Siarhei | stock.adobe.com
May 15th 2025

FDA Grants Orphan Drug Designation to Oligonucleotide Therapeutic for Spinocerebellar Ataxia

Kennedy Ferruggia, Assistant Editor
X-ray image depicting a migraine -- Image credit: peterschreiber.media | stock.adobe.com
May 15th 2025

FDA Approves Brekiya, First and Only DHE Autoinjector, for Acute Treatment of Migraine, Cluster Headaches

Gillian McGovern, Associate Editor